S&P 500   3,307.26 (-0.44%)
DOW   29,016.34 (-0.58%)
QQQ   223.38 (-0.22%)
AAPL   316.93 (-0.24%)
FB   220.54 (-0.35%)
MSFT   165.98 (+0.17%)
GOOGL   1,488.81 (+0.31%)
AMZN   1,878.28 (-0.49%)
CGC   24.37 (+1.04%)
NVDA   248.55 (-0.60%)
BABA   218.17 (-1.89%)
MU   59.35 (+0.29%)
GE   11.62 (+2.20%)
AMD   50.90 (-1.03%)
ACB   2.06 (+0.98%)
F   8.96 (-2.18%)
NFLX   328.69 (+0.83%)
BAC   33.82 (-1.57%)
DIS   142.35 (-1.15%)
GILD   63.02 (-0.65%)
S&P 500   3,307.26 (-0.44%)
DOW   29,016.34 (-0.58%)
QQQ   223.38 (-0.22%)
AAPL   316.93 (-0.24%)
FB   220.54 (-0.35%)
MSFT   165.98 (+0.17%)
GOOGL   1,488.81 (+0.31%)
AMZN   1,878.28 (-0.49%)
CGC   24.37 (+1.04%)
NVDA   248.55 (-0.60%)
BABA   218.17 (-1.89%)
MU   59.35 (+0.29%)
GE   11.62 (+2.20%)
AMD   50.90 (-1.03%)
ACB   2.06 (+0.98%)
F   8.96 (-2.18%)
NFLX   328.69 (+0.83%)
BAC   33.82 (-1.57%)
DIS   142.35 (-1.15%)
GILD   63.02 (-0.65%)
S&P 500   3,307.26 (-0.44%)
DOW   29,016.34 (-0.58%)
QQQ   223.38 (-0.22%)
AAPL   316.93 (-0.24%)
FB   220.54 (-0.35%)
MSFT   165.98 (+0.17%)
GOOGL   1,488.81 (+0.31%)
AMZN   1,878.28 (-0.49%)
CGC   24.37 (+1.04%)
NVDA   248.55 (-0.60%)
BABA   218.17 (-1.89%)
MU   59.35 (+0.29%)
GE   11.62 (+2.20%)
AMD   50.90 (-1.03%)
ACB   2.06 (+0.98%)
F   8.96 (-2.18%)
NFLX   328.69 (+0.83%)
BAC   33.82 (-1.57%)
DIS   142.35 (-1.15%)
GILD   63.02 (-0.65%)
S&P 500   3,307.26 (-0.44%)
DOW   29,016.34 (-0.58%)
QQQ   223.38 (-0.22%)
AAPL   316.93 (-0.24%)
FB   220.54 (-0.35%)
MSFT   165.98 (+0.17%)
GOOGL   1,488.81 (+0.31%)
AMZN   1,878.28 (-0.49%)
CGC   24.37 (+1.04%)
NVDA   248.55 (-0.60%)
BABA   218.17 (-1.89%)
MU   59.35 (+0.29%)
GE   11.62 (+2.20%)
AMD   50.90 (-1.03%)
ACB   2.06 (+0.98%)
F   8.96 (-2.18%)
NFLX   328.69 (+0.83%)
BAC   33.82 (-1.57%)
DIS   142.35 (-1.15%)
GILD   63.02 (-0.65%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NYSE:PG - Procter & Gamble Stock Price, Forecast & News

$125.94
-0.37 (-0.29 %)
(As of 01/23/2020 10:03 AM ET)
Today's Range
$124.00
Now: $125.94
$126.55
50-Day Range
$121.99
MA: $124.79
$126.41
52-Week Range
$89.08
Now: $125.94
$127.00
Volume2.26 million shs
Average Volume5.55 million shs
Market Capitalization$314.07 billion
P/E Ratio83.96
Dividend Yield2.37%
Beta0.4
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments; and skin and personal care products, such as antiperspirants and deodorants, and personal cleansing and skin care products under the Head & Shoulders, Pantene, Rejoice, Olay, Old Spice, Safeguard, and SK-II brands. Read More…

Industry, Sector and Symbol

Industry Soap, detergents, & cleaning preparations; perfumes, & cosmetics
Sub-IndustryHousehold Products
SectorConsumer Staples
CUSIP74271810
Phone513-983-1100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$67.68 billion
Cash Flow$5.85 per share
Book Value$18.60 per share

Profitability

Net Income$3.90 billion

Miscellaneous

Employees97,000
Outstanding Shares2,493,810,000
Market Cap$314.07 billion
Next Earnings Date1/23/2020 (Confirmed)
OptionableOptionable

Receive PG News and Ratings via Email

Sign-up to receive the latest news and ratings for PG and its competitors with MarketBeat's FREE daily newsletter.


Procter & Gamble (NYSE:PG) Frequently Asked Questions

What is Procter & Gamble's stock symbol?

Procter & Gamble trades on the New York Stock Exchange (NYSE) under the ticker symbol "PG."

How often does Procter & Gamble pay dividends? What is the dividend yield for Procter & Gamble?

Procter & Gamble announced a quarterly dividend on Tuesday, January 14th. Investors of record on Friday, January 24th will be paid a dividend of $0.7459 per share on Tuesday, February 18th. This represents a $2.98 annualized dividend and a yield of 2.38%. The ex-dividend date of this dividend is Thursday, January 23rd. View Procter & Gamble's Dividend History.

How were Procter & Gamble's earnings last quarter?

Procter & Gamble Co (NYSE:PG) posted its quarterly earnings data on Thursday, January, 23rd. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.37 by $0.05. The company had revenue of $18.24 billion for the quarter, compared to the consensus estimate of $18.37 billion. Procter & Gamble had a return on equity of 25.07% and a net margin of 6.24%. The company's revenue for the quarter was up 4.6% on a year-over-year basis. During the same period last year, the business posted $1.25 earnings per share. View Procter & Gamble's Earnings History.

When is Procter & Gamble's next earnings date?

Procter & Gamble is scheduled to release their next quarterly earnings announcement on Thursday, January 23rd 2020. View Earnings Estimates for Procter & Gamble.

What guidance has Procter & Gamble issued on next quarter's earnings?

Procter & Gamble issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, January, 23rd. The company provided earnings per share (EPS) guidance of 4.88-5.02 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.94. The company issued revenue guidance of $70.391-71.068 billion, compared to the consensus revenue estimate of $70.63 billion.

What price target have analysts set for PG?

15 analysts have issued 12 month price targets for Procter & Gamble's stock. Their forecasts range from $89.00 to $139.00. On average, they anticipate Procter & Gamble's share price to reach $120.38 in the next year. This suggests that the stock has a possible downside of 4.2%. View Analyst Price Targets for Procter & Gamble.

What is the consensus analysts' recommendation for Procter & Gamble?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Procter & Gamble in the last year. There are currently 1 sell rating, 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Procter & Gamble.

What are Wall Street analysts saying about Procter & Gamble stock?

Here are some recent quotes from research analysts about Procter & Gamble stock:
  • 1. Wells Fargo & Co analysts commented, "We continue to expect money will chase companies that have momentum and are delivering, and PG should be a primary beneficiary. We are raising our price target by $10 to $135 and reiterate our Outperform rating." (7/30/2019)
  • 2. According to Zacks Investment Research, "Procter & Gamble surpassed the industry in the past six months owing to robust earnings trend, strong second-quarter fiscal 2019 results and upbeat view for fiscal 2019. Top and bottom line beat estimates in the fiscal second quarter, marking 15th straight earnings beat and fifth sales beat in the last six quarters. Earnings benefited from the tax reforms, while strong organic growth with higher shipment volumes and favorable price/mix boosted sales. The company raised the sales guidance for fiscal 2019. It is also gaining from focus on product improvement, packaging and marketing initiatives, and productivity and cost-savings plan. However, it is witnessing strained margins owing to increased commodity and shipping costs, higher brand investments and aggressive pricing from private-label products amid intense competition. Moreover, adverse currency rates are hurting P&G’s results, which is likely to continue in fiscal 2019." (3/26/2019)

Has Procter & Gamble been receiving favorable news coverage?

Media coverage about PG stock has been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Procter & Gamble earned a coverage optimism score of 1.6 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Procter & Gamble.

Who are some of Procter & Gamble's key competitors?

What other stocks do shareholders of Procter & Gamble own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Procter & Gamble investors own include Johnson & Johnson (JNJ), AT&T (T), Verizon Communications (VZ), Cisco Systems (CSCO), Walt Disney (DIS), The Coca-Cola (KO), Exxon Mobil (XOM), Intel (INTC), General Electric (GE) and Pfizer (PFE).

Who are Procter & Gamble's key executives?

Procter & Gamble's management team includes the folowing people:
  • Mr. David S. Taylor, Chairman, CEO & Pres (Age 61)
  • Mr. Jon R. Moeller, CFO & Vice Chairman (Age 55)
  • Ms. Mary Lynn Ferguson-McHugh, Group Pres of Global Family Care and P&G Ventures (Age 59)
  • Mr. Stephen D. Bishop, Group Pres of Global Health Care (Age 55)
  • Ms. Kathleen B. Fish, Chief Research, Devel. & Innovation Officer (Age 62)

Who are Procter & Gamble's major shareholders?

Procter & Gamble's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Johanson Financial Advisors Inc. (0.10%), Assenagon Asset Management S.A. (0.08%), PGGM Investments (0.05%), Gateway Investment Advisers LLC (0.05%), Calamos Advisors LLC (0.04%) and Nisa Investment Advisors LLC (0.04%). Company insiders that own Procter & Gamble stock include Carolyn M Tastad, Ciserani Giovanni, David S Taylor, Deborah P Majoras, Gary A Coombe, Ioannis Skoufalos, Jeffrey K Schomburger, Jon R Moeller, Juan Fernando Posada, Kathleen B Fish, Loic Tassel, Ma Fatima Francisco, Marc S Pritchard, Mary Theresa Grabowski, Marylynn Fergusonmchugh, Nelson Peltz, Price Matthew, R Alexandra Keith, Shailesh Jejurikar, Steven D Bishop, Trian Fund Management, LP and Valarie L Sheppard. View Institutional Ownership Trends for Procter & Gamble.

Which major investors are selling Procter & Gamble stock?

PG stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Marathon Asset Management LLP, Hexavest Inc., Commerzbank Aktiengesellschaft FI, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Janney Montgomery Scott LLC, IFP Advisors Inc and State of Alaska Department of Revenue. Company insiders that have sold Procter & Gamble company stock in the last year include Carolyn M Tastad, David S Taylor, Deborah P Majoras, Gary A Coombe, Ioannis Skoufalos, Jeffrey K Schomburger, Jon R Moeller, Juan Fernando Posada, Loic Tassel, Ma Fatima Francisco, Marc S Pritchard, Mary Theresa Grabowski, Marylynn Fergusonmchugh, Nelson Peltz, Price Matthew, R Alexandra Keith, Shailesh Jejurikar, Steven D Bishop, Trian Fund Management, LP and Valarie L Sheppard. View Insider Buying and Selling for Procter & Gamble.

Which major investors are buying Procter & Gamble stock?

PG stock was purchased by a variety of institutional investors in the last quarter, including Johanson Financial Advisors Inc., Assenagon Asset Management S.A., Huntington National Bank, TRH Financial LLC, Candriam Luxembourg S.C.A., Beacon Financial Group, Bowling Portfolio Management LLC and Baxter Bros Inc.. View Insider Buying and Selling for Procter & Gamble.

How do I buy shares of Procter & Gamble?

Shares of PG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Procter & Gamble's stock price today?

One share of PG stock can currently be purchased for approximately $125.60.

How big of a company is Procter & Gamble?

Procter & Gamble has a market capitalization of $313.22 billion and generates $67.68 billion in revenue each year. The company earns $3.90 billion in net income (profit) each year or $4.52 on an earnings per share basis. Procter & Gamble employs 97,000 workers across the globe.View Additional Information About Procter & Gamble.

What is Procter & Gamble's official website?

The official website for Procter & Gamble is http://us.pg.com/.

How can I contact Procter & Gamble?

Procter & Gamble's mailing address is One Procter & Gamble Plaza, Cincinnati OH, 45202. The company can be reached via phone at 513-983-1100 or via email at [email protected]


MarketBeat Community Rating for Procter & Gamble (NYSE PG)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  774 (Vote Outperform)
Underperform Votes:  925 (Vote Underperform)
Total Votes:  1,699
MarketBeat's community ratings are surveys of what our community members think about Procter & Gamble and other stocks. Vote "Outperform" if you believe PG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel